Company Search:
Advanced Search
Sponsored Links
Corcept Therapeutics Incorporated Company Snapshot
Corcept Therapeutics Incorporated operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Corcept Therapeutics Incorporated with three other companies in this sector in the United States: Reliv' International, Inc. (2015 sales of $51.77 million ), Array BioPharma Inc. ($51.91 million of which 100% was Small Molecular Drugs), and Ophthotech Corp ($51.51 million ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Corcept Therapeutics Incorporated
  Stock Performance Chart for Corcept Therapeutics Incorporated
  Stock Data: Recent Stock Performance:
  Current Price (2/17/2017): 8.30
(Figures in U.S. Dollars)
1 Week 0.3%   13 Weeks 12.1%  
4 Weeks -12.2%   52 Weeks 111.1%  
Corcept Therapeutics Incorporated Key Data:
  Ticker: CORT Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 50,286,000
(Year Ending Jan 2016).
Employees: 83
  Currency: U.S. Dollars Market Cap: 921,008,466
  Fiscal Yr Ends: December Shares Outstanding: 111,031,762
  Share Type: Common Closely Held Shares: 14,587,254
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.